Skip to content
zameds

Epinephrine bitartrate (Medihaler Epi)

Epinephrine bitartrate

Inova Pharmaceuticals (Pty) Ltd

Registration

Applicant
Inova Pharmaceuticals (Pty) Ltd
Registrations
1

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Medihaler epi

1 ML EPINEPHRINE BITARTRATE A 14,0 MG

Not listedG0844Old MedicineNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S4: Epinephrine

    • when intended for injection.

    Consolidated Schedules 06 July 2026, line 6203

  • S3: Adrenaline

    • ophthalmic preparations thereof, when intended for glaucoma.

    Consolidated Schedules 06 July 2026, line 3122

  • S2: Adrenaline

    • ophthalmic preparations when intended for glaucoma, and
    • preparations for injection. (S3, S4)

    Consolidated Schedules 06 July 2026, lines 1561 to 1565

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C9H13NO3183.20 g/mol

4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]benzene-1,2-diol

Drag to rotate. Structure from PubChem CID 5816.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles